Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study.

Tesauro C, Simonsen AK, Andersen MB, Petersen KW, Kristoffersen EL, Algreen L, Hansen NY, Andersen AB, Jakobsen AK, Stougaard M, Gromov P, Knudsen BR, Gromova I.

BMC Cancer. 2019 Nov 29;19(1):1158. doi: 10.1186/s12885-019-6371-0.

2.

Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics.

Jabeen S, Espinoza JA, Torland LA, Zucknick M, Kumar S, Haakensen VD, Lüders T, Engebraaten O, Børresen-Dale AL, Kyte JA, Gromov P, Naume B, Kristensen V, Gromova I, Tekpli X.

Oncoimmunology. 2018 Nov 5;8(2):e1537691. doi: 10.1080/2162402X.2018.1537691. eCollection 2019.

3.

N-glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome.

Terkelsen T, Haakensen VD, Saldova R, Gromov P, Hansen MK, Stöckmann H, Lingjaerde OC, Børresen-Dale AL, Papaleo E, Helland Å, Rudd PM, Gromova I.

Mol Oncol. 2018 Jun;12(6):972-990. doi: 10.1002/1878-0261.12312. Epub 2018 May 14.

4.

Identification of BLCAP as a novel STAT3 interaction partner in bladder cancer.

Gromova I, Svensson S, Gromov P, Moreira JMA.

PLoS One. 2017 Nov 30;12(11):e0188827. doi: 10.1371/journal.pone.0188827. eCollection 2017.

5.

Gaining insights into cancer biology through exploration of the cancer secretome using proteomic and bioinformatic tools.

Papaleo E, Gromova I, Gromov P.

Expert Rev Proteomics. 2017 Nov;14(11):1021-1035. doi: 10.1080/14789450.2017.1387053. Epub 2017 Oct 6. Review.

PMID:
28967788
6.

RHEB1 insufficiency in aged male mice is associated with stress-induced seizures.

Tian Q, Gromov P, Clement JH, Wang Y, Riemann M, Weih F, Sun XX, Dai MS, Fedorov LM.

Geroscience. 2017 Dec;39(5-6):557-570. doi: 10.1007/s11357-017-9997-3. Epub 2017 Sep 10.

7.

Profiling of microRNAs in tumor interstitial fluid of breast tumors - a novel resource to identify biomarkers for prognostic classification and detection of cancer.

Halvorsen AR, Helland Å, Gromov P, Wielenga VT, Talman MM, Brunner N, Sandhu V, Børresen-Dale AL, Gromova I, Haakensen VD.

Mol Oncol. 2017 Feb;11(2):220-234. doi: 10.1002/1878-0261.12025. Epub 2016 Dec 12.

8.

Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.

Espinoza JA, Jabeen S, Batra R, Papaleo E, Haakensen V, Timmermans Wielenga V, Møller Talman ML, Brunner N, Børresen-Dale AL, Gromov P, Helland Å, Kristensen VN, Gromova I.

Oncoimmunology. 2016 Oct 24;5(12):e1248015. doi: 10.1080/2162402X.2016.1248015. eCollection 2016.

9.

Characterization of the Tumor Secretome from Tumor Interstitial Fluid (TIF).

Gromov P, Gromova I.

Methods Mol Biol. 2016;1459:231-47. doi: 10.1007/978-1-4939-3804-9_16.

PMID:
27665563
10.

Molecular and diagnostic features of apocrine breast lesions.

Gromov P, Espinoza JA, Gromova I.

Expert Rev Mol Diagn. 2015;15(8):1011-22. doi: 10.1586/14737159.2015.1057125. Epub 2015 Jun 25. Review.

PMID:
26111757
11.

High level PHGDH expression in breast is predominantly associated with keratin 5-positive cell lineage independently of malignancy.

Gromova I, Gromov P, Honma N, Kumar S, Rimm D, Talman ML, Wielenga VT, Moreira JM.

Mol Oncol. 2015 Oct;9(8):1636-54. doi: 10.1016/j.molonc.2015.05.003. Epub 2015 May 14.

12.

FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast.

Gromov P, Espinoza JA, Talman ML, Honma N, Kroman N, Timmermans Wielenga V, Moreira JM, Gromova I.

PLoS One. 2014 Nov 12;9(11):e112024. doi: 10.1371/journal.pone.0112024. eCollection 2014.

13.

Proteomic analysis of tissue samples in translational breast cancer research.

Gromov P, Moreira JM, Gromova I.

Expert Rev Proteomics. 2014 Jun;11(3):285-302. doi: 10.1586/14789450.2014.899469. Epub 2014 Mar 20. Review.

PMID:
24837673
14.

Tumor interstitial fluid - a treasure trove of cancer biomarkers.

Gromov P, Gromova I, Olsen CJ, Timmermans-Wielenga V, Talman ML, Serizawa RR, Moreira JM.

Biochim Biophys Acta. 2013 Nov;1834(11):2259-70. doi: 10.1016/j.bbapap.2013.01.013. Epub 2013 Feb 14. Review.

PMID:
23416532
15.

Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.

Cabezón T, Gromova I, Gromov P, Serizawa R, Timmermans Wielenga V, Kroman N, Celis JE, Moreira JM.

Mol Cell Proteomics. 2013 Feb;12(2):381-94. doi: 10.1074/mcp.M112.019786. Epub 2012 Nov 20.

16.

Immunoexpression analysis and prognostic value of BLCAP in breast cancer.

Gromova I, Gromov P, Kroman N, Wielenga VT, Simon R, Sauter G, Moreira JM.

PLoS One. 2012;7(9):e45967. doi: 10.1371/journal.pone.0045967. Epub 2012 Sep 25.

17.

Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.

Moreira JM, Cabezón T, Gromova I, Gromov P, Timmermans-Wielenga V, Machado I, Llombart-Bosch A, Kroman N, Rank F, Celis JE.

Mol Oncol. 2010 Dec;4(6):539-61. doi: 10.1016/j.molonc.2010.09.005. Epub 2010 Oct 8.

18.

Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker.

Gromov P, Gromova I, Friis E, Timmermans-Wielenga V, Rank F, Simon R, Sauter G, Moreira JM.

J Proteome Res. 2010 Aug 6;9(8):3941-53. doi: 10.1021/pr100160u.

PMID:
20527979
19.

Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.

Gromov P, Gromova I, Bunkenborg J, Cabezon T, Moreira JM, Timmermans-Wielenga V, Roepstorff P, Rank F, Celis JE.

Mol Oncol. 2010 Feb;4(1):65-89. doi: 10.1016/j.molonc.2009.11.003. Epub 2009 Nov 23.

20.

Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer.

Moreira JM, Ohlsson G, Gromov P, Simon R, Sauter G, Celis JE, Gromova I.

Mol Cell Proteomics. 2010 Jan;9(1):161-77. doi: 10.1074/mcp.M900294-MCP200. Epub 2009 Sep 25.

21.

Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort.

Celis JE, Cabezón T, Moreira JM, Gromov P, Gromova I, Timmermans-Wielenga V, Iwase T, Akiyama F, Honma N, Rank F.

Mol Oncol. 2009 Jun;3(3):220-37. doi: 10.1016/j.molonc.2009.01.005. Epub 2009 Feb 3.

22.

A single lysis solution for the analysis of tissue samples by different proteomic technologies.

Gromov P, Celis JE, Gromova I, Rank F, Timmermans-Wielenga V, Moreira JM.

Mol Oncol. 2008 Dec;2(4):368-79. doi: 10.1016/j.molonc.2008.09.003. Epub 2008 Oct 2.

23.

Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis.

Li J, Gromov P, Gromova I, Moreira JM, Timmermans-Wielenga V, Rank F, Wang K, Li S, Li H, Wiuf C, Yang H, Zhang X, Bolund L, Celis JE.

Proteomics. 2008 Dec;8(23-24):5038-52. doi: 10.1002/pmic.200800303.

PMID:
19003862
24.

15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma.

Celis JE, Gromov P, Cabezón T, Moreira JM, Friis E, Jirström K, Llombart-Bosch A, Timmermans-Wielenga V, Rank F, Gromova I.

Mol Cell Proteomics. 2008 Oct;7(10):1795-809. doi: 10.1074/mcp.R800011-MCP200. Epub 2008 Jul 16.

25.

Proteomic strategies in bladder cancer: From tissue to fluid and back.

Gromov P, Moreira JM, Gromova I, Celis JE.

Proteomics Clin Appl. 2008 Jul;2(7-8):974-88. doi: 10.1002/prca.200780163. Epub 2008 Jul 10.

PMID:
21136898
26.

[Computer simulation of complex formation between plastocyanine and cytochrome f in thylakoid lumen].

Kovalenko IB, Abaturova AM, Gromov PA, Ustinin DM, Riznichenko GIu, Grachev EA, Rubin AB.

Biofizika. 2008 Mar-Apr;53(2):261-70. Russian.

PMID:
18543768
27.

A combined proteome and ultrastructural localization analysis of 14-3-3 proteins in transformed human amnion (AMA) cells: definition of a framework to study isoform-specific differences.

Moreira JM, Shen T, Ohlsson G, Gromov P, Gromova I, Celis JE.

Mol Cell Proteomics. 2008 Jul;7(7):1225-40. doi: 10.1074/mcp.M700439-MCP200. Epub 2008 Mar 31.

28.

Human Proteinpedia enables sharing of human protein data.

Mathivanan S, Ahmed M, Ahn NG, Alexandre H, Amanchy R, Andrews PC, Bader JS, Balgley BM, Bantscheff M, Bennett KL, Björling E, Blagoev B, Bose R, Brahmachari SK, Burlingame AS, Bustelo XR, Cagney G, Cantin GT, Cardasis HL, Celis JE, Chaerkady R, Chu F, Cole PA, Costello CE, Cotter RJ, Crockett D, DeLany JP, De Marzo AM, DeSouza LV, Deutsch EW, Dransfield E, Drewes G, Droit A, Dunn MJ, Elenitoba-Johnson K, Ewing RM, Van Eyk J, Faca V, Falkner J, Fang X, Fenselau C, Figeys D, Gagné P, Gelfi C, Gevaert K, Gimble JM, Gnad F, Goel R, Gromov P, Hanash SM, Hancock WS, Harsha HC, Hart G, Hays F, He F, Hebbar P, Helsens K, Hermeking H, Hide W, Hjernø K, Hochstrasser DF, Hofmann O, Horn DM, Hruban RH, Ibarrola N, James P, Jensen ON, Jensen PH, Jung P, Kandasamy K, Kheterpal I, Kikuno RF, Korf U, Körner R, Kuster B, Kwon MS, Lee HJ, Lee YJ, Lefevre M, Lehvaslaiho M, Lescuyer P, Levander F, Lim MS, Löbke C, Loo JA, Mann M, Martens L, Martinez-Heredia J, McComb M, McRedmond J, Mehrle A, Menon R, Miller CA, Mischak H, Mohan SS, Mohmood R, Molina H, Moran MF, Morgan JD, Moritz R, Morzel M, Muddiman DC, Nalli A, Navarro JD, Neubert TA, Ohara O, Oliva R, Omenn GS, Oyama M, Paik YK, Pennington K, Pepperkok R, Periaswamy B, Petricoin EF, Poirier GG, Prasad TS, Purvine SO, Rahiman BA, Ramachandran P, Ramachandra YL, Rice RH, Rick J, Ronnholm RH, Salonen J, Sanchez JC, Sayd T, Seshi B, Shankari K, Sheng SJ, Shetty V, Shivakumar K, Simpson RJ, Sirdeshmukh R, Siu KW, Smith JC, Smith RD, States DJ, Sugano S, Sullivan M, Superti-Furga G, Takatalo M, Thongboonkerd V, Trinidad JC, Uhlen M, Vandekerckhove J, Vasilescu J, Veenstra TD, Vidal-Taboada JM, Vihinen M, Wait R, Wang X, Wiemann S, Wu B, Xu T, Yates JR, Zhong J, Zhou M, Zhu Y, Zurbig P, Pandey A.

Nat Biotechnol. 2008 Feb;26(2):164-7. doi: 10.1038/nbt0208-164. No abstract available.

29.

Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.

Celis JE, Gromova I, Cabezón T, Gromov P, Shen T, Timmermans-Wielenga V, Rank F, Moreira JM.

Mol Oncol. 2007 Dec;1(3):321-49. doi: 10.1016/j.molonc.2007.09.004. Epub 2007 Sep 25.

30.

Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer.

Cabezón T, Celis JE, Skibshøj I, Klingelhöfer J, Grigorian M, Gromov P, Rank F, Myklebust JH, Maelandsmo GM, Lukanidin E, Ambartsumian N.

Int J Cancer. 2007 Oct 1;121(7):1433-44.

31.

Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.

Celis JE, Moreira JM, Gromova I, Cabezón T, Gromov P, Shen T, Timmermans V, Rank F.

Mol Oncol. 2007 Jun;1(1):97-119. doi: 10.1016/j.molonc.2007.02.005. Epub 2007 Mar 14.

32.

Direct simulation of plastocyanin and cytochrome f interactions in solution.

Kovalenko IB, Abaturova AM, Gromov PA, Ustinin DM, Grachev EA, Riznichenko GY, Rubin AB.

Phys Biol. 2006 Jun 5;3(2):121-9.

PMID:
16829698
33.

Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia.

Celis JE, Gromova I, Gromov P, Moreira JM, Cabezón T, Friis E, Rank F.

FEBS Lett. 2006 May 22;580(12):2935-44. Epub 2006 Apr 12. Review.

34.

Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype.

Celis JE, Gromov P, Moreira JM, Cabezón T, Friis E, Vejborg IM, Proess G, Rank F, Gromova I.

Mol Cell Proteomics. 2006 Mar;5(3):462-83. Epub 2005 Nov 28.

35.

Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells.

Andersen H, Mejlvang J, Mahmood S, Gromova I, Gromov P, Lukanidin E, Kriajevska M, Mellon JK, Tulchinsky E.

Mol Cell Biol. 2005 Oct;25(20):9138-50.

36.

Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas.

Ohlsson G, Moreira JM, Gromov P, Sauter G, Celis JE.

Mol Cell Proteomics. 2005 Apr;4(4):570-81. Epub 2005 Feb 25.

38.

Towards discovery-driven translational research in breast cancer.

Celis JE, Moreira JM, Gromova I, Cabezon T, Ralfkiaer U, Guldberg P, Straten PT, Mouridsen H, Friis E, Holm D, Rank F, Gromov P.

FEBS J. 2005 Jan;272(1):2-15. Review.

39.

Impact of proteomics on bladder cancer research.

Celis JE, Gromova I, Moreira JM, Cabezon T, Gromov P.

Pharmacogenomics. 2004 Jun;5(4):381-94. Review.

PMID:
15165174
40.

Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.

Celis JE, Gromov P, Cabezón T, Moreira JM, Ambartsumian N, Sandelin K, Rank F, Gromova I.

Mol Cell Proteomics. 2004 Apr;3(4):327-44. Epub 2004 Jan 30.

42.

Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research.

Celis JE, Gromov P, Gromova I, Moreira JM, Cabezón T, Ambartsumian N, Grigorian M, Lukanidin E, Thor Straten P, Guldberg P, Bartkova J, Bartek J, Lukas J, Lukas C, Lykkesfeldt A, Jäättelä M, Roepstorff P, Bolund L, Ørntoft T, Brünner N, Overgaard J, Sandelin K, Blichert-Toft M, Mouridsen H, Rank FE.

Mol Cell Proteomics. 2003 Jun;2(6):369-77. Epub 2003 Jun 25.

44.

Proteomics in translational cancer research: toward an integrated approach.

Celis JE, Gromov P.

Cancer Cell. 2003 Jan;3(1):9-15. Review.

45.

Human proteomic databases: a powerful resource for functional genomics in health and disease.

Gromov PS, Østergaard M, Gromova I, Celis JE.

Prog Biophys Mol Biol. 2002 Jul-Aug;80(1-2):3-22. Review.

PMID:
12231220
46.

Proteomic strategies to reveal tumor heterogeneity among urothelial papillomas.

Celis JE, Celis P, Palsdottir H, Østergaard M, Gromov P, Primdahl H, Ørntoft TF, Wolf H, Celis A, Gromova I.

Mol Cell Proteomics. 2002 Apr;1(4):269-79.

47.
48.
49.

[From genomics to proteomics].

Gromov PS, Celis JE.

Mol Biol (Mosk). 2000 Jul-Aug;34(4):597-611. Review. Russian. No abstract available.

PMID:
11042852
50.

Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics.

Celis JE, Kruhøffer M, Gromova I, Frederiksen C, Ostergaard M, Thykjaer T, Gromov P, Yu J, Pálsdóttir H, Magnusson N, Orntoft TF.

FEBS Lett. 2000 Aug 25;480(1):2-16. Review.

Supplemental Content

Loading ...
Support Center